Table 3.
Significant gene expression difference in the analysis of PTSD cases and controls.
| Gene | Region | Sample | logfc | pvalue | pcor |
|---|---|---|---|---|---|
| GLP2R | vmPFC | Female | 3.92 | 5.12E-10 | 9.80E-05 |
| MBP | vmPFC | Female | −1.46 | 1.72E-09 | 0.00016 |
| OTOGLa | dlPFC | Male | −0.55 | 6.72E-09 | 0.00043 |
| MOBPa | vmPFC | Female | −1.49 | 4.80E-08 | 0.0021 |
| MAFF | vmPFC | Male | 1.89 | 5.58E-08 | 0.0021 |
| PAIP2B | vmPFC | Female | −1.55 | 1.56E-07 | 0.005 |
| PIRT | vmPFC | Complete | 2.11 | 4.87E-07 | 0.013 |
| LPAR1 | vmPFC | Female | −1.48 | 5.75E-07 | 0.013 |
| KPNA1 | dlPFC | Complete | 0.17 | 5.95E-07 | 0.013 |
| CFHa | vmPFC | Male | −1.11 | 8.93E-07 | 0.017 |
| SLC2A14 | dlPFC | Male | −2.88 | 9.71E-07 | 0.017 |
| PCDH8 | vmPFC | Female | 2.08 | 1.07E-06 | 0.017 |
| FOSa | vmPFC | Female | 2.14 | 1.76E-06 | 0.026 |
| BCAS1 | vmPFC | Female | −1.42 | 2.11E-06 | 0.028 |
| ZDHHC11B | vmPFC | Female | −1.81 | 2.20E-06 | 0.028 |
| ERMN | vmPFC | Female | −1.21 | 2.75E-06 | 0.033 |
| NR4A1 | vmPFC | Female | 2.64 | 4.31E-06 | 0.046 |
| EDN1a | dlPFC | Complete | 1.3 | 4.40E-06 | 0.046 |
| KIF5A | vmPFC | Female | −1.13 | 4.58E-06 | 0.046 |
| RBM3 | dlPFC | Female | 1.88 | 4.98E-06 | 0.046 |
| EMP1 | vmPFC | Male | 1.56 | 5.03E-06 | 0.046 |
a
Indicates that the association was supported in the data from the dlPFC in Girgenti et al. See Results: Comparison to Prior Results section for details.